CTOR

Citius Oncology, Inc. Common Stock

6 hedge funds and large institutions have $97.7K invested in Citius Oncology, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-5
Holders Change %
-45.45%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
UBS Group
1
UBS Group
Switzerland
$46.3K +$23.2K +24,940 +101%
IA
2
IFP Advisors
Florida
$20.7K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$19.1K +$7.34K +7,888 +62%
YCM
4
Yakira Capital Management
Connecticut
$11.2K
Osaic Holdings
5
Osaic Holdings
Arizona
$325 -$4.76K -5,130 -94%
Bank of America
6
Bank of America
North Carolina
$149
HF
7
HRT Financial
New York
-$78K -68,543 Closed
Citadel Advisors
8
Citadel Advisors
Florida
-$26.1K -22,699 Closed
XT
9
XTX Topco
Cayman Islands
-$24.3K -21,095 Closed
Renaissance Technologies
10
Renaissance Technologies
New York
-$12.9K -11,196 Closed
TRCT
11
Tower Research Capital (TRC)
New York
-$47 -41 Closed